IQVIA (France)

Recent papers from IQVIA (France)

1. Increased risk of cardiovascular events in the weeks following hospitalised COPD exacerbations: the EXACOS-CV French nationwide case-crossover studyEuropean Heart Journal · 2024
2. Vision and Foraging in Structurally Complex Habitats: Common Moorhens ( Gallinula chloropus ) See the Way AheadEcology and Evolution · 2026
3. Whooping cough hospitalisations among patients with chronic conditions: a retrospective analysis of incidence and costs, France, 2008 to 2020Eurosurveillance · 2026
4. Analysis of care-pathways of older adults hospitalized for influenza-like illness before institutionalization: a French SNDS-based studyBMC Health Services Research · 2026
5. Assessing the association of physical distancing to avoid COVID-19 with health-related quality of life in immunocompromised adults: results from the cross-sectional observational EAGLE studyBMJ Public Health · 2026
6. Respiratory syncytial virus in adults aged ≥ 50 years in France: a database and time-series modelling analysis (2014–2020)Infection · 2026
7. Safety of Remibrutinib in Chronic Spontaneous Urticaria: A Pooled Analysis of REMIX-1 and REMIX-2 TrialsThe Journal of Allergy and Clinical Immunology In Practice · 2026
8. Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions—Part 2Journal of Nuclear Medicine · 2026
9. Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions—Part 1Journal of Nuclear Medicine · 2026
10. Evaluating pertussis vaccine effectiveness in children under 5 years of age born in France between 2013 and 2019Vaccine · 2026
11. Ten-Year Trends in Healthcare Use and Costs for People Living with Diabetes in France: Results from the Epicodiab Study Based on National Claims DataDiabetes Therapy · 2026
12. Contemporary Guideline-Directed Medical Therapy for Heart Failure in the United States: The EMPACE Study.2026
13. Understanding the lived experience of colorectal cancer: a qualitative study of patient and clinician perspectivesJournal of Cancer Survivorship · 2026
14. Abstract RF6-07: Trastuzumab deruxtecan (T-DXd) + pertuzumab (P) vs taxane + trastuzumab + pertuzumab (THP) for first-line (1L) treatment of patients (pts) with HER2-positive (HER2+) advanced/metastatic breast cancer (a/mBC): patient-reported outcomes (PROs) from the DESTINY-Breast09 studyClinical Cancer Research · 2026
15. Adopting a Societal Perspective in Health-Economic Evaluation: Analysis of Nine HTA Methodological Guidelines on How to Integrate Societal CostsJournal of Market Access & Health Policy · 2026
16. Sieving for gold: external comparator studies to prioritize drugs for late-stage clinical trialJournal of Comparative Effectiveness Research · 2026
17. Five‐Grass‐Pollen Sublingual Immunotherapy Drops Are Efficacious and Well Tolerated in Adults: The RHAPSODY Phase III TrialAllergy · 2025
18. Impact of Liquid Sublingual Immunotherapy on Health Care Resource Use in Allergic Rhinitis and Asthma in the Real-world EfficAPSI StudyJournal of Investigational Allergology and Clinical Immunology · 2025
19. A qualitative interview study exploring the lived experiences of adults, adolescents, and children with chronic inducible cold urticariaJournal of Patient-Reported Outcomes · 2025
20. Temporal trajectories and DMARD therapy retention of rheumatoid arthritis patients with different autoimmune and inflammatory comorbidity profiles: a retrospective analysisJournal of Autoimmunity · 2025